S Romain
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Pathology and Forensic Medicine top 10%
- Genetics
- Co-authors
- P.M. MartinF. SpyratosPierre MartinPascal BonnierFréderic FinaL’Houcine OuafikJohn A. FoekensJ. P. Palmari
- Topics
- Estrogen and related hormone effects (10 papers)HER2/EGFR in Cancer Research (9 papers)Breast Cancer Treatment Studies (9 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteBritish Journal of Cancer
- Partner nations
- FranceNetherlandsSweden
In The Last Decade
S Romain
39 papers receiving 938 citations
Peers
Comparison fields: 5 of 72
- Oncology 611
- Molecular Biology 348
- Cancer Research 316
- Pathology and Forensic Medicine 185
- Genetics 128
Countries citing papers authored by S Romain
This map shows the geographic impact of S Romain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Romain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Romain more than expected).
Fields of papers citing papers by S Romain
This network shows the impact of papers produced by S Romain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Romain. The network helps show where S Romain may publish in the future.
Co-authorship network of co-authors of S Romain
This figure shows the co-authorship network connecting the top 25 collaborators of S Romain. A scholar is included among the top collaborators of S Romain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Romain. S Romain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 71 | |
| 3 | 17 | |
| 4 | 68 | |
| 5 | Multivariate analyses of flow cytometric S-phase and ploidy as node-negative breast cancer prognostic factors : an international and multi-center study | 1 |
| 6 | 77 | |
| 7 | 20 | |
| 8 | 38 | |
| 9 | 25 | |
| 10 | 3 | |
| 11 | 41 | |
| 12 | 10 | |
| 13 | 13 | |
| 14 | 16 | |
| 15 | 10 | |
| 16 | 41 | |
| 17 | 4 | |
| 18 | [Prognostic value of thymidine kinase in cancer of the breast]. | 9 |
| 19 | 12 | |
| 20 | 60 |
About S Romain
S Romain is a scholar working on Cancer Research, Oncology and Genetics, having authored 43 papers that have together received 965 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), HER2/EGFR in Cancer Research (9 papers) and Breast Cancer Treatment Studies (9 papers). The work is most often cited by research in Oncology (611 citations), Cancer Research (316 citations) and Pathology and Forensic Medicine (185 citations). S Romain has collaborated with scholars based in France, Netherlands and Sweden. Frequent co-authors include P.M. Martin, F. Spyratos, Pierre Martin, Pascal Bonnier, Fréderic Fina, L’Houcine Ouafik, John A. Foekens, J. P. Palmari, H Magdelénat and M. Ferrero-Poüs. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.